These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16932279)

  • 1. Long-term, low-dose flutamide does not cause hepatotoxicity in hyperandrogenic women.
    Legro RS
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):188-9. PubMed ID: 16932279
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
    Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
    Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
    Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
    Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antiandrogens as therapy for women with polycystic ovary syndrome.
    Moghetti P
    Fertil Steril; 2006 Jul; 86 Suppl 1():S30-1. PubMed ID: 16798285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss.
    Paradisi R; Porcu E; Fabbri R; Seracchioli R; Battaglia C; Venturoli S
    Ann Pharmacother; 2011 Apr; 45(4):469-75. PubMed ID: 21487083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females.
    Bruni V; Peruzzi E; Dei M; Nannini S; Seravalli V; Sisti G; Fambrini M
    Fertil Steril; 2012 Oct; 98(4):1047-52. PubMed ID: 22795685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
    Castelo-Branco C; Moyano D; Gómez O; Balasch J
    Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which treatment options should be used in adolescents with polycystic ovary syndrome?
    Villa P; Di Sebastiano F; Rossodivita A; Sagnella F; Barini A; Fulghesu AM; Lanzone A
    J Pediatr Endocrinol Metab; 2004 May; 17(5):705-10. PubMed ID: 15237703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity with flutamide.
    Karaahmet F; Kurt K
    Fertil Steril; 2012 Nov; 98(5):e27; author reply e28. PubMed ID: 22985946
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term satisfaction and tolerability with low-dose flutamide: a 20-year surveillance study on 120 hyperandrogenic women.
    Castelo-Branco C; Hernández-Angeles C; Alvarez-Olivares L; Balasch J
    Gynecol Endocrinol; 2016 Sep; 32(9):723-727. PubMed ID: 27176209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
    Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
    Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
    Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome.
    Sahin I; Serter R; Karakurt F; Demirbas B; Guler S; Culha C; Taskapan C; Aral Y
    Horm Res; 2003; 60(5):232-6. PubMed ID: 14614228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity during low-dose flutamide treatment for hirsutism.
    Castelo-Branco C; Del Pino M
    Gynecol Endocrinol; 2009 Jul; 25(7):419-22. PubMed ID: 19903043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide for androgen excess: low dose is best.
    de Zegher F; Ibáñez L
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):e43-4. PubMed ID: 21376280
    [No Abstract]   [Full Text] [Related]  

  • 20. How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
    Diamanti-Kandarakis E
    J Endocrinol Invest; 1998 Oct; 21(9):623-9. PubMed ID: 9856417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.